for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Market News

BRIEF-Vbl Therapeutics Announces Q1 Loss Per Share $0.24

May 17 (Reuters) - Vascular Biogenics Ltd:

* VBL THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.24

* SAYS CASH, CASH EQUIVALENTS AND SHORT-TERM BANK DEPOSITS AT MARCH 31, 2018, WERE $49.9 MILLION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up